Skip to main content
. 2019 Jan 30;22:101131. doi: 10.1016/j.redox.2019.101131

Table 3.

Effects of digoxin on the sensitivity of SW1990/Gem and Panc-1/Gem cells to different anticancer drugs.

Group SW1990/Gem
Panc-1/Gem
IC50 RF IC50 RF
Gemcitabine (μM) Control 519.59 ± 31.14 1 283.47 ± 21.7 1
Digoxin 20 nM 98.55 ± 6.12 5.27 72.47 ± 6 3.91
Digoxin 40 nM 37.18 ± 4.75 13.97 39.54 ± 4.61 7.17
Digoxin 80 nM 14.5 ± 2.03 35.83 13.87 ± 2.16 20.43


 

 

 

 


Etoposide (μM) Control 633.19 ± 40.77 1 445.82 ± 30.85 1
Digoxin 20 nM 445.77 ± 22.04 1.42 327.28 ± 20.82 1.36
Digoxin 40 nM 232.98 ± 18.38 2.72 172.46 ± 10.57 2.59
Digoxin 80 nM 110.95 ± 13.63 5.71 119.34 ± 12.85 3.74


 

 

 

 


Paclitaxel (nM) Control 293.07 ± 19.72 1 216.53 ± 16.27 1
Digoxin 20 nM 209.57 ± 17.65 1.4 144.27 ± 11.57 1.5
Digoxin 40 nM 61.04 ± 4.99 4.8 67.82 ± 4.05 3.19
Digoxin 80 nM 35.77 ± 4.31 8.19 37.01 ± 4.99 5.85


 

 

 

 


Cisplatin (μM) Control 186.47 ± 11.41 1 155.53 ± 11.78 1
Digoxin 20 nM 112.87 ± 8.52 1.65 107.17 ± 7.35 1.45
Digoxin 40 nM 86.24 ± 6.39 2.16 68.15 ± 6.24 2.28
Digoxin 80 nM 51.73 ± 6.28 3.6 58.44 ± 6.06 2.66


 

 

 

 


5-FU (μM) Control 185.38 ± 14.67 1 168.39 ± 10.8 1
Digoxin 20 nM 118.23 ± 10.08 1.57 110.88 ± 7.6 1.52
Digoxin 40 nM 86.55 ± 7.17 2.14 73.46 ± 7.73 2.29
Digoxin 80 nM 55.25 ± 7.06 3.36 38.89 ± 4.72 4.33


 

 

 

 


Ara-C (μM) Control 16.88 ± 1.15 1 10.93 ± 0.96 1
Digoxin 20 nM 11.4 ± 1.07 1.48 8.5 ± 0.74 1.29
Digoxin 40 nM 6.65 ± 0.5 2.54 4.66 ± 0.3 2.35
Digoxin 80 nM 2.99 ± 0.32 5.65 1.61 ± 0.33 6.79


 

 

 

 


Doxorubicin (μM) Control 29.24 ± 2.74 1 24.4 ± 1.84 1
Digoxin 20 nM 14.03 ± 1.54 2.08 15.02 ± 1.68 1.62
Digoxin 40 nM 11.06 ± 1.19 2.64 10.82 ± 1.16 2.26
Digoxin 80 nM 6.74 ± 0.47 4.34 7.52 ± 0.92 3.24

Effects of digoxin on the sensitivity of SW1990/Gem and Panc-1/Gem cells to different anticancer drugs were detected by MTT assay. Data were expressed as mean ± SD of three independent experiments.